JADBio
Specializes in no-code AI for predictive modeling and feature selection, enabling rapid insights from multi-omics data for biomarker discovery and disease research.
Overview
JADBio offers advanced AI technology that simplifies predictive modeling and feature selection through a no-code platform. This technology is integrated into Black Arrow Biotech's proprietary peptide screening platform, enhancing the ability to derive key insights and make objective decisions efficiently.
The platform is capable of parsing multi-omics data, including genomics, transcriptomics, metagenomics, proteomics, metabolomics, phenotype/clinical data, and images. This capability allows for fast and efficient discovery of insights necessary for various applications.
Applications and Conditions
- Cancer – Oncology: Early biomarker discovery, time to event analysis, and phenotypic trait identification.
- Immune, Endocrine, Metabolic Systems: Early biomarker discovery, disease subtype/stage analysis, and phenotypic trait identification.
- Chronic Diseases, Aging: Drug repurposing, phenotypic trait analysis, and chemosensitivity studies.
- Infectious Diseases: Lead identification, compound optimization, and trial monitoring.
- Mental Health: Response to treatment, safety, efficiency, and dosage studies.
JADBio's research has been featured in prominent publications such as Nature, Precision Oncology, and Cell Press, Cancer Cell, highlighting its contributions to automated predictive modeling and classification of cancer samples.